Showing results (131-140 of 3,351) with videos related to

Sort By:
Pageof 336
The Lancet. Oncology|March 8, 2021
Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trialJoël Guigay, Anne Aupérin, Jérôme Fayette, et al.
The Lancet. Oncology|November 3, 2022
Progress and remaining challenges for cancer control in the Gulf Cooperation CouncilSamar Alhomoud, Saleh Al-Othman, Amal Al-Madouj, et al.
The Lancet. Oncology|November 3, 2022
Exploring the link between cancer policies and cancer survival: a comparison of International Cancer Benchmarking Partnership countriesEllen Nolte, Melanie Morris, Susan Landon, et al.
The Lancet. Oncology|October 14, 2022
Treatment-related thoracic soft tissue sarcomas in US breast cancer survivors: a retrospective cohort studyLene H S Veiga, Jacqueline B Vo, Rochelle E Curtis, et al.
The Lancet. Oncology|October 20, 2022
Association of the interaction between mosaic chromosomal alterations and polygenic risk score with the risk of lung cancer: an array-based case-control association and prospective cohort studyNa Qin, Cheng Wang, Congcong Chen, et al.
The Lancet. Oncology|October 20, 2022
Continuous enzalutamide after progression of metastatic castration-resistant prostate cancer treated with docetaxel (PRESIDE): an international, randomised, phase 3b studyAxel S Merseburger, Gerhardt Attard, Lennart Åström, et al.
The Lancet. Oncology|March 11, 2021
Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): a multicentre, open-label, randomised, phase 3 trialTingyan Shi, Jianqing Zhu, Yanling Feng, et al.
The Lancet. Oncology|March 25, 2021
Real-time fluorescence imaging in intraoperative decision making for cancer surgeryLorraine J Lauwerends, Pieter B A A van Driel, Robert J Baatenburg de Jong, et al.
The Lancet. Oncology|July 19, 2011
EGFR exon 20 insertion mutations in non-small-cell lung cancer: preclinical data and clinical implicationsHiroyuki Yasuda, Susumu Kobayashi, Daniel B Costa
The Lancet. Oncology|July 5, 2011
Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility studyTom Treasure, Loic Lang-Lazdunski, David Waller, et al.
Pageof 336